Testing a new medicine (galegenimab) to find out if it is effective for a type of eye disease (geographic atrophy secondary to age-related macular degeneration)
A Study Assessing the Safety, Tolerability, and Efficacy of RO7171009 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
Eye Disorder Macular Degeneration Age-Related Macular Degeneration Dry Macular Degeneration Geographic Atrophy
For the latest version of this information please go to www.forpatients.roche.com